Skip to content

TEG-Guided blood product transfusion in cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)

Effect of TEG-Guided blood product transfusion on prognosis of patients in cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000028835
Enrollment
Unknown
Registered
2020-01-05
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal carcinoma

Interventions

T-BT group:the anesthesiologist will inject blood products according to experience
TEG-BT group:TEG guided blood transfusion

Sponsors

Beijing Shijitan Hospital Affiliated to Capital University of Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 64 years; 2. American association of anesthesiologists (ASA) I or II; 3. Histologic diagnosis of peritoneal disease has been well established; 4. CRS combined with HIPEC was performed under general anesthesia; 5. Written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Anemia; 2.Abnormal coagulation function before surgery; 3.Uncontrolled systemic infections; 4.Long-term anticoagulant therapy; 5.Severe cardiopulmonary disease; 6.Hepatic or renal failure; 7.Pregnancy or lactation; 8.The patient refused to sign the informed consent; 9.The patient also participated in another clinical treatment study.

Design outcomes

Primary

MeasureTime frame
Perioperative blood transfusion volume;Transfusion volume;Transfusion volume of blood products;The amount of blood lost 72 hours after suegery;Lactic acid;BE;HGB;ph;glucose;K;Na;Cl;

Secondary

MeasureTime frame
The amount of blood lost during the operation;Transfusion volume during the operation;Transfusion volume of blood products;Indicators of coagulation function;The lowest hemoglobin;ICU duration;Overall length of stay;The cost during the hospital;

Countries

China

Contacts

Public ContactLihong Shen

Beijing Shijitan Hospital Affiliated to Capital university of Medical

32430835@qq.com+86 13020071810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026